Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2006 2
2007 5
2008 2
2009 5
2010 3
2011 10
2012 1
2013 1
2014 3
2015 4
2016 1
2018 3
2019 2
2020 1
2021 5
2022 2
2023 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Codon-specific translation reprogramming promotes resistance to targeted therapy.
Rapino F, Delaunay S, Rambow F, Zhou Z, Tharun L, De Tullio P, Sin O, Shostak K, Schmitz S, Piepers J, Ghesquière B, Karim L, Charloteaux B, Jamart D, Florin A, Lambert C, Rorive A, Jerusalem G, Leucci E, Dewaele M, Vooijs M, Leidel SA, Georges M, Voz M, Peers B, Büttner R, Marine JC, Chariot A, Close P. Rapino F, et al. Among authors: rorive a. Nature. 2018 Jun;558(7711):605-609. doi: 10.1038/s41586-018-0243-7. Epub 2018 Jun 20. Nature. 2018. PMID: 29925953
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
Okines AFC, Curigliano G, Mizuno N, Oh DY, Rorive A, Soliman H, Takahashi S, Bekaii-Saab T, Burkard ME, Chung KY, Debruyne PR, Fox JR, Gambardella V, Gil-Martin M, Hamilton EP, Monk BJ, Nakamura Y, Nguyen D, O'Malley DM, Olawaiye AB, Pothuri B, Reck M, Sudo K, Sunakawa Y, Van Marcke C, Yu EY, Ramos J, Tan S, Bieda M, Stinchcombe TE, Pohlmann PR. Okines AFC, et al. Among authors: rorive a. Nat Med. 2025 Mar;31(3):909-916. doi: 10.1038/s41591-024-03462-0. Epub 2025 Jan 17. Nat Med. 2025. PMID: 39825152 Free PMC article. Clinical Trial.
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.
Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, Forsea AM, Gebhardt C, Gershenwald JE, Hamid O, Hoeller C, Kandolf L, Kaufmann R, Kirkwood JM, Lebbé C, Long GV, Malvehy J, Martin-Algarra S, McArthur G, Neyns B, Richtig E, Robert C, Schadendorf D, Scolyer R, Sondak VK, Wainstein A, Weichenthal M, Nuti P; Melanoma World Society Study Group. Hauschild A, et al. Lancet Oncol. 2025 Jan;26(1):12-14. doi: 10.1016/S1470-2045(24)00627-2. Lancet Oncol. 2025. PMID: 39756440 No abstract available.
Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study.
Onesti CE, Schroeder H, Rorive A, Sautois B, Lecocq M, Goffin M, Gonne E, Collinge A, Nicolaers L, Wéra O, Catot A, Loly C, Paulus A, Sibille A, Lousberg L, Troisfontaine F, Collignon J, Gennigens C, Frères P, Polus M, Duysinx B, Vaillant F, Marchal N, Poncin A, Jerusalem G. Onesti CE, et al. Among authors: rorive a. Cancer Rep (Hoboken). 2022 Oct;5(10):e1571. doi: 10.1002/cnr2.1571. Epub 2021 Oct 12. Cancer Rep (Hoboken). 2022. PMID: 34636178 Free PMC article.
Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy.
Pottier C, Montero-Ruiz L, Jehay R, Wery C, Baiwir D, Mazzucchelli G, Bekisz S, Thissen R, Josse C, Rorive A, Gofflot S, Dahmani A, Morisset L, Collignon J, Delvenne P, Marangoni E, Noël A, Jerusalem G, Sounni NE. Pottier C, et al. Among authors: rorive a. Cancer Commun (Lond). 2025 Apr;45(4):460-464. doi: 10.1002/cac2.12646. Epub 2025 Jan 13. Cancer Commun (Lond). 2025. PMID: 39801257 Free PMC article. No abstract available.
[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
Jerusalem G, Collignon J, Josse C, Schroeder H, Rorive A, Frères P, Lambert F, Koopmansch B, Poncin A, Bours V. Jerusalem G, et al. Among authors: rorive a. Rev Med Liege. 2015 May-Jun;70(5-6):269-76. Rev Med Liege. 2015. PMID: 26285451 Free article. Review. French.
56 results